Metabolomics News

Environmental Factor - April 2022: "All of Us" Research Program a boon to personalized health, biomedicine  Environmental Factor Newsletter

Environmental Factor - April 2022: Extramural Papers of the Month  Environmental Factor Newsletter

April 2022: Environmental exposures underpin many metabolic diseases, expert says  Environmental Factor Newsletter

Metabolomics Market Size, Share, Statistics, Trends, Types, Applications, Analysis and Forecast to 2029 – FortBendNow  FortBendNow

In-depth Mitochondrial Function Testing Services at Creative Biogene  Digital Journal

Vegans Boast a Greater Abundance of Disease-Fighting Biomarkers than Do Non-Vegetarians  Adventist News Network

Scent Back: Süskind's Perfume Could Come To Life As German Scientists Recreate Smells From The Past  Birmingham Times

Scent Back: Süskind's Perfume Could Come To Life As German Scientists Recreate Smells From The Past  Birmingham Times

Joris Deelen to present at the 9th Aging Research & Drug Discovery Meeting 2022  EurekAlert

Researchers identify two distinct tuberculosis subtypes – implications for personalized therapy  EurekAlert

Novel metabolic biomarker predicts Parkinson's disease from an early stage  BioWorld Online

Healthful eating patterns, serum metabolite profile and risk of diabetes in a population-based prospective study of US Hispanics/Latinos  DocWire News

Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer  DocWire News

Sumitomo Dainippon Pharma Co., Ltd. - National Cancer Center Japan, Shonai Regional Industry Promotion Center and Sumitomo Dainippon Pharma Announce Start of Phase 1/2 Study on New Drug Candidate Compound  Marketscreener.com

Using ML to Identify Metabolomic Signatures of Pediatric CKD Etiology  Physician's Weekly

Companion Diagnostics Development Services Market : Distribution by Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key Geographies : Industry Trends and Global Forecasts, 2022-2035  Yahoo Finance

Plasma metabolomics reveals disrupted response and recovery following maximal exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome  DocWire News

Plasma metabolomics reveals disrupted response and recovery following maximal exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome  DocWire News

Plasma metabolomics reveals disrupted response and recovery following maximal exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome  DocWire News

Sumitomo Dainippon Pharma : National Cancer Center Japan, Shonai Regional Industry Promotion Center and Sumitomo Dainippon Pharma Announce Start of Phase 1/2 Study on New Drug Candidate Compound in Acute Myeloid Leukemia  Marketscreener.com